Editorial: Use of Artificial Intelligence to evaluate drug-related behavioral changes in rodents.

Front Pharmacol

Department of Pharmacology, Faculty of Medicine and Biomedical Research Center, Neurosciences Institute, Biosanitary Research Institute ibs.GRANADA, University of Granada, Granada, Spain.

Published: April 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11066194PMC
http://dx.doi.org/10.3389/fphar.2024.1396454DOI Listing

Publication Analysis

Top Keywords

editorial artificial
4
artificial intelligence
4
intelligence evaluate
4
evaluate drug-related
4
drug-related behavioral
4
behavioral changes
4
changes rodents
4
editorial
1
intelligence
1
evaluate
1

Similar Publications

Introduction: Screening diabetic retinopathy (DR) for timely management can reduce global blindness. Many existing DR screening programs worldwide are non-digital, standalone, and deployed with grading retinal photographs by trained personnel. To integrate the screening programs, with or without artificial intelligence (AI), into hospital information systems to improve their effectiveness, the non-digital workflow must be transformed into digital.

View Article and Find Full Text PDF

Greater than the sum of its parts: multimodality imaging in adults with congenital heart disease.

Cardiovasc Diagn Ther

December 2024

Department of Heart, Vascular & Thoracic, Division of Cardiology & Cardiovascular Medicine - Pediatric Cardiology, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.

As the population of adults with congenital heart disease (ACHD) grows, there also grows an expanded need for non-invasive surveillance methods to guide management and intervention. A multimodal imaging approach layers complementary insights from echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and other modalities into a clinician's view of patient physiology. Merely applying strategies from acquired adult cardiac disease would be inadequate and potentially misleading.

View Article and Find Full Text PDF

Intelligent biology and medicine: Accelerating innovative computational approaches.

Comput Struct Biotechnol J

November 2024

Center for Precision Health, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

In this editorial, we summarize the 2023 International Conference on Intelligent Biology and Medicine (ICIBM 2023) conference which was held on July 16-19, 2023 in Tampa, Florida, USA. We then briefly describe the nine research articles included in this special issue. ICIBM 2023 scientific program included four tutorials and workshops, four keynote lectures, four eminent scholars' presentations, 11 concurrent scientific sessions, and a poster session.

View Article and Find Full Text PDF

The TRIPOD-LLM reporting guideline for studies using large language models.

Nat Med

January 2025

Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.

Large language models (LLMs) are rapidly being adopted in healthcare, necessitating standardized reporting guidelines. We present transparent reporting of a multivariable model for individual prognosis or diagnosis (TRIPOD)-LLM, an extension of the TRIPOD + artificial intelligence statement, addressing the unique challenges of LLMs in biomedical applications. TRIPOD-LLM provides a comprehensive checklist of 19 main items and 50 subitems, covering key aspects from title to discussion.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!